HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Gilead Sciences, Inc. (GILD)
76.32  1.61  (2.15%) 07-13 03:15
Open: 76.1 High: 76.85
Pre.close: 74.71 Low: 75.52
Volume: 9,553,834 Ave vol: 16,113,071
52w High: 85.97 52w Low: 60.89
MA(50): 75.464 MA(200): 72.843
EPS: 3.896 P/E Ratio: 19.59
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug ManufacturersGeneral
Website: http://www.gilead.com
Market Cap (M): 95,734
Shares Out (M): 1,254
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases. It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bullish
Target 1: 92.63 Target 2: 108.20
Resist 1: 79.31 Resist 2: 92.63
Support 1: 74.74 Support 2: 71.91
Company key metrics
Revenue per Share: 17.6764
Net Income per Share: 4.2409
Cash per Share: 9.1583
Book Value per Share: 17.7362
Price to Sales: 3.6223
Price to Book Value: 3.6101
Earnings Yield: 0.0662
Dividend Yield: 0.0396
Debt to Equity: 1.7359
Debt to Assets: 0.6345
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Outperform
Debt to Equity: Outperform
Stock Charts
Headline news
Sun, 12 Jul 2020
Is Gilead Sciences a Good Coronavirus Stock to Buy? - The Motley Fool

Sat, 11 Jul 2020
Why Gilead Sciences' Successful COVID-19 Results Fell Flat - Motley Fool

Thu, 02 Jul 2020
Were Hedge Funds Right About Buying Gilead Sciences, Inc. (GILD)? - Yahoo Finance

Mon, 22 Jun 2020
What to Do with Gilead Sciences (GILD) Stock Right Now? - Yahoo Finance

Mon, 29 Jun 2020
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Fri, 03 Jul 2020
What Kind Of Shareholders Own Gilead Sciences, Inc. (NASDAQ:GILD)? - Simply Wall St

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.